Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 12458
Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704113(US20240368204, Compound 40)
Affinity DataIC50: 0.0600nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704108(US20240368204, Compound 30)
Affinity DataIC50: 0.200nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704112(US20240368204, Compound 38)
Affinity DataIC50: 0.300nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704100(US20240368204, Compound 12)
Affinity DataIC50: 0.400nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704103(US20240368204, Compound 25)
Affinity DataIC50: 0.400nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704109(US20240368204, Compound 31)
Affinity DataIC50: 0.700nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704106(US20240368204, Compound 28)
Affinity DataIC50: 0.700nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704110(US20240368204, Compound 32)
Affinity DataIC50: 0.900nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704111(US20240368204, Compound 33)
Affinity DataIC50: 1.20nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704105(US20240368204, Compound 27)
Affinity DataIC50: 1.70nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704101(US20240368204, Compound 18)
Affinity DataIC50: 1.80nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704107(US20240368204, Compound 29)
Affinity DataIC50: 2.60nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704104(US20240368204, Compound 26)
Affinity DataIC50: 2.90nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5'-nucleotidase(Human)
Xizang Haisco Pharmaceutical

US Patent
LigandPNGBDBM704102(US20240368204, Compound 24)
Affinity DataIC50: 5.30nMAssay Description:Human recombinant protein CD73 (Acro, Cat. No. CD3-H52H7) was prepared into a 0.04 ng/μL protein solution, and substrate AMP (Sigma, Cat. No. A1752-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent